Financials Adlai Nortye Ltd.

Equities

ANL

US00704R1095

Biotechnology & Medical Research

Market Closed - Nasdaq 04:30:00 2024-05-13 pm EDT 5-day change 1st Jan Change
13 USD -0.38% Intraday chart for Adlai Nortye Ltd. +2.12% +44.61%

Valuation

Fiscal Period: December 2023 2024 2025 2026
Capitalization 1 331.7 479.7 - -
Enterprise Value (EV) 1 331.7 479.7 479.7 479.7
P/E ratio - - - -
Yield - - - -
Capitalization / Revenue 54.4 x - - 1.43 x
EV / Revenue 54.4 x - - 1.43 x
EV / EBITDA - - - -
EV / FCF - - -4,037,908 x 6,852,907 x
FCF Yield - - -0% 0%
Price to Book - - - -
Nbr of stocks (in thousands) 36,900 36,900 - -
Reference price 2 8.990 13.00 13.00 13.00
Announcement Date 4/19/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025 2026
Net sales 1 - 6.098 - - 335.4
EBITDA - - - - -
EBIT 1 - -10.54 -91.5 -150 88.9
Operating Margin - -172.92% - - 26.51%
Earnings before Tax (EBT) - - - - -
Net income -58.79 - - - -
Net margin - - - - -
EPS -2.310 - - - -
Free Cash Flow - - - -118.8 70
FCF margin - - - - 20.87%
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 7/27/23 4/19/24 - - -
1USD in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2024 S2 2025 Q1
Net sales 1 - - - - - - -
EBITDA - - - - - - -
EBIT - - - - - - -
Operating Margin - - - - - - -
Earnings before Tax (EBT) - - - - - - -
Net income - - - - - - -
Net margin - - - - - - -
EPS - - - - - - -
Dividend per Share - - - - - - -
Announcement Date - - - - - - -
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025 2026
Net Debt - - - - -
Net Cash position - - - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - - - -119 70
ROE (net income / shareholders' equity) - - - - -
ROA (Net income/ Total Assets) - - - - -
Assets - - - - -
Book Value Per Share - - - - -
Cash Flow per Share - - - - -
Capex 1 - - 2.5 2.5 2.5
Capex / Sales - - - - 0.75%
Announcement Date 7/27/23 4/19/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
13
Average target price
-
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. ANL Stock
  4. Financials Adlai Nortye Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW